TAVR vs SAVR in low-risk and high-risk patients: a randomized trial meta-analysis
A meta-analysis of randomized trials comparing TAVR to surgical aortic valve replacement (SAVR) found that while the risk of death or stroke resulting in death or disability was lower in the TAVR group up to 1 year in low-risk patients, there was no difference after 1 year. There was no significant difference in the primary outcome between the two treatments at 1 year and after 1 year in high-risk patients, Dr. Yousif Ahmad of Yale University, USA, and colleagues reported in the March 7 issue of the European Heart Journal.
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Recommendations
